Wolfgang Barth

Keine laufenden Positionen mehr

Health Technology

Finance

Consumer Services

Profil

Wolfgang Barth is currently working as a Development Director at AC Immune SA since 2013.
Previously, he held positions as a Director-Project Management at Bayer Corp., a Principal at Bayer AG, and a Member-Supervisory Board at Hypothekenbank Frankfurt AG.
From 2004 to 2008, he served as a Vice President-Development at Avontec GmbH.
He also worked as the Head-Development at TRIN Pharma GmbH.
Dr. Barth holds a doctorate degree from Philipps University of Marburg.

Ehemalige bekannte Positionen von Wolfgang Barth

Unternehmen	Position	Ende
Avontec GmbH Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease	Corporate Officer/Principal	18.06.2008
Hypothekenbank Frankfurt AG Hypothekenbank Frankfurt AG Financial ConglomeratesFinance Mortgage Bank	Direktor/Vorstandsmitglied	13.07.2006
TRIN Pharma GmbH TRIN Pharma GmbH Medical/Nursing ServicesHealth Services Develops small molecule drugs for an effective tumor treatment	Corporate Officer/Principal	-
AC IMMUNE SA	Corporate Officer/Principal	-
BAYER AG	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Wolfgang Barth im Detail an

Ausbildung von Wolfgang Barth

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Wolfgang Barth im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	7
Bayer Corp. Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products	Health Technology
Bayer AG Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services	Health Technology
AC Immune SA AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases	Health Technology
Hypothekenbank Frankfurt AG Hypothekenbank Frankfurt AG Financial ConglomeratesFinance Mortgage Bank	Finance
Avontec GmbH Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease	Health Technology
Philipps University of Marburg Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
TRIN Pharma GmbH TRIN Pharma GmbH Medical/Nursing ServicesHealth Services Develops small molecule drugs for an effective tumor treatment	Health Services